AbbVie Says Evidence Doesn't Back $140M AndroGel Verdict
AbbVie Inc. asked an Illinois federal judge to enter judgment in its favor in the second bellwether trial over claims the company failed to warn consumers about risks accompanying its drug...To view the full article, register now.
Already a subscriber? Click here to view full article